S0727 Gemcitabine Hydrochloride and Erlotinib Hydrochloride With or Without Monoclonal Antibody Therapy in Treating Patients With Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery
Clinical trial NCT00617708 · COMPLETED
Trial details
- NCT number
- NCT00617708
- Sponsor
- National Cancer Institute (NCI)
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-03-01
- Primary completion
- 2012-09-01
- Enrollment
- 134
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.